Cmed’s CEO talks to Innovations in Pharmaceutical Technology.

Written by Cmed

Cmed’s CEO David Connelly shares his thoughts on how new technology can revolutionise and streamline data and trial processes in this month’s issue of Innovations in Pharmaceutical Technology.

Amongst others things, he walks us through the different methodologies used to capture data and how technology is now shaping the way CROs work. Want to learn more? You can read the full article here

This article is taken from Innovations in Pharmaceutical Technology January 2018, pages 14-15. © Samedan Ltd.